Sale!

Research paper on Evaluation of Rituximab-Related Clinical Hypersensitivity in Patients with B-Cell Neoplasia

Original price was: ₹21,240.00.Current price is: ₹10,620.00. inc. GST

Research paper on Evaluation of Rituximab-Related Clinical Hypersensitivity in Patients with B-Cell Neoplasia

1 in stock

Description

Title: Evaluation of Rituximab-Related Clinical Hypersensitivity in Patients with B-Cell Neoplasia

Abstract: Although they are uncommon, rituximab hypersensitivity reactions are one of the main reasons that it is removed from antilymphoma immunochemotherapy regimens. Hypersensitivity reactions (HSR) do not go away with subsequent administrations but rather intensify, even though the clinical picture may be difficult to distinguish from other infusion-related reactions. Objective. To explain the application of the 12-step protocol for rituximab desensitization in clinical practice and the complementary investigation of a potential IgE-mediated HSR in the context of rituximab treatment for B-cell lymphoma. Methods. Ten patients with a history of severe infusion reactions or patients who experienced a repeat reaction despite taking more stringent preventive measures underwent a 12-step rituximab desensitization protocol prospectively in clinical practice. In order to eliminate false negatives brought on by potential drug interference, skin prick tests were carried out both immediately after the reaction and later. Results. In general, 70% of patients were able to complete the planned immunochemotherapy thanks to the desensitization protocol. Due to clinical persistence in two patients and lymphoma progression in the third, the therapy had to be stopped in both cases. Only 20% of intradermal tests with 0.1% rituximab were positive, indicating a hypersensitive mechanism. Conclusions. The 12-step protocol for desensitization is extremely effective and widely accepted in medical practice. Due to the possibility of future drug exposure, it is necessary to identify the mechanism underlying the infusion reaction in a significant number of cases.

Paper Quality: SCOPUS / Web of Science Level Research Paper

Subject: Medicine

Sub Category: Hematology

Writer Experience: 20+ Years

Plagiarism Report: Turnitin Plagiarism Report will be less than 10%

Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.

What will I get after the purchase?

A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.

In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.